L-Tyrosine: Stress Resilience, Focus, and What the Evidence Shows

L-tyrosine is best supported as a short-term cognitive aid during acute stress—cold exposure, sleep loss, heavy military-style demands, or difficult working-memory tasks—not as a daily mood, ADHD, thyroid, or exercise supplement. It is a precursor to dopamine, norepinephrine, epinephrine, thyroid hormones T3/T4, and melanin, but extra precursor does not automatically mean more of each pathway in a predictable or safe way. The biggest safety flags are MAOIs, Parkinson's levodopa medicines, thyroid medication, stimulants, high-dose caffeine, and other catecholamine-raising stacks.

Table of Contents

• Evidence summary
• What it is
• All forms and types of L-tyrosine
• How it works
• What works and what doesn't
• Benefits with evidence grades
• Risks and all side effects
• All interactions
• Who should avoid it
• Dosage and how to take it
• Infographics and text equivalents
• Frequently asked questions
• Sources

Evidence Summary

Claim	Evidence	Source country	Funding / conflict tracing	Strength
Acute-stress cognition	Human trials and reviews suggest benefit mainly during cold, sleep deprivation, operational stress, or very demanding tasks.	USA, Netherlands, UK/USA mixed review	Many early studies originated in US military or Dutch military-linked settings; a 2015 Military Medicine review was supported by the Defense Health Program and USUHS Human Performance Resource Center.	Moderate
Working memory	Small placebo-controlled studies show benefit in difficult N-back or cold-stress tasks, but older-adult dose-response work found worse high-load working memory at higher doses.	Netherlands, USA	Netherlands N-back study reported no commercial conflicts and NWO funding; older-adult dose-response study reported EFRO/Dutch provincial/NWO funding and no conflicts.	Mixed-to-moderate
Physical performance / exercise	Heat and sport studies are inconsistent; multiple trials found no performance benefit.	UK, USA, Türkiye-linked authorship	2025 soccer study reported no specific funding and no competing interests; one caffeine-theanine-tyrosine athlete trial was funded by Nature's Bounty and had company-employed authors, so it is downgraded.	Weak / mixed
ADHD	One open adult ADD trial showed initial response but tolerance by week 6; one small single-blind child ADDH trial found no significant improvement.	USA	Funding not disclosed in PubMed records; evidence is old, small, and not robustly blinded.	Insufficient
Depression	A 65-person double-blind trial found no antidepressant activity versus placebo.	USA	Funding not disclosed in PubMed abstract; trial design is stronger than open reports and weighs against benefit.	Doesn't work for routine depression
PKU supplementation	Cochrane review found higher blood tyrosine but no significant clinical outcome differences across included trials.	UK / international review	Cochrane methods; review included three suitable trials with 56 people and judged evidence too small for routine recommendation.	Biochemical effect; insufficient clinical benefit
Form choice	Free-form L-tyrosine has the best human oral evidence; NALT is more soluble but poorly converted in human IV studies; tyrosine ethyl ester lacks human supplement evidence.	USA/Europe mixed	NALT human work in clinical nutrition; no supplement-company funding found in PubMed abstract, but some later sports/nootropic commentary is commercial and excluded.	Moderate for L-tyrosine over NALT

> Primary-source quote: “Most of these articles originated from research units attached to the US military; other publications originated from universities and the Dutch military,” wrote Simon N. Young in Journal of Psychiatry & Neuroscience when evaluating the stress-claim evidence base (Journal of Psychiatry & Neuroscience).

What it is

L-tyrosine is a conditionally essential aromatic amino acid made from phenylalanine and obtained from protein-rich foods such as dairy, meat, fish, eggs, seeds, nuts, and beans (Nutrients). In supplement form, it is usually sold as free-form L-tyrosine powder or capsules, or as N-acetyl-L-tyrosine (NALT), a more water-soluble acetylated derivative (PubMed).

The active compound(s) — what actually does the work

The relevant active compound for most nootropic claims is free L-tyrosine, because it raises plasma tyrosine and can increase the tyrosine-to-other-large-neutral-amino-acids ratio that favors transport toward the brain (Nutrients). NALT must be deacetylated into free tyrosine before it can act as tyrosine, and a human infusion study found only a 25% plasma tyrosine increase while 56% of the infused NALT was excreted in urine within four hours (PubMed). Tyrosine ethyl ester has essentially no human oral supplement evidence, so claims that it is a superior nootropic form should be treated as unproven. > Primary-source quote: In the NALT human infusion study, the authors concluded that “the usefulness of NAT and NAC as precursors for the corresponding amino acids in humans is not apparent” (PubMed).

All forms and grades

Form	What it is	Bioavailability evidence	Best use	Cost / availability	Verdict
Free-form L-tyrosine	The standard amino-acid form used in most stress and cognition trials.	Human studies show dose-dependent plasma increases; 100–150 mg/kg typically peaks around 90–120 minutes in acute studies.	Research-style acute stress dosing; cautious low-dose nootropic use.	Common globally and .	Best-studied form.
N-acetyl-L-tyrosine (NALT; acetyl-L-tyrosine)	Acetylated tyrosine derivative with better water solubility.	Human IV data show poor conversion: 5 g IV NALT raised plasma tyrosine only 25% and 56% was excreted in urine.	Useful in some parenteral nutrition formulations; not clearly better for nootropics.	Common in nootropic blends; often marketed as “more bioavailable,” which human data do not support.	More soluble, not more bioavailable.
Tyrosine ethyl ester	Esterified tyrosine form sometimes discussed as a prodrug-style form.	No credible human oral supplement trials were found; old biochemical work shows tyrosine ethyl ester can undergo liver sulfation reactions, but this does not establish oral nootropic bioavailability.	Research chemistry, not routine supplementation.	Rare in mainstream India supplements.	Insufficient evidence.

Original insight: the “solubility = bioavailability” shortcut fails for tyrosine; NALT dissolves better, but the bottleneck is conversion back to usable tyrosine, not dissolution. Cited stat: 56% urinary excretion of NALT after a 5 g IV infusion is a strong warning that NALT is an inefficient tyrosine source in humans (PubMed). Primary-source quote: a mouse prodrug study found that N-acetyl-L-tyrosine was “the least effective prodrug tested,” while methyl ester and O-phospho-L-tyrosine performed better in that animal model (PubMed).

How it works

What the body does with it

Tyrosine sits at a biochemical crossroads: it can be used for protein synthesis, converted into catecholamines, incorporated into thyroid hormone chemistry, and used in melanogenesis. NCBI Bookshelf describes catecholamines—dopamine, norepinephrine, and epinephrine—as derived from tyrosine through tyrosine hydroxylase converting tyrosine to L-DOPA, followed by conversion to dopamine and onward to norepinephrine and epinephrine (NCBI Bookshelf). PubChem's tyrosine metabolism pathway also lists tyrosine as a source for L-DOPA, dopamine, adrenaline, noradrenaline, thyroxine, triiodothyronine, and melanin (PubChem PathBank).

Why form and delivery matter

Brain uptake depends less on total tyrosine alone and more on the ratio of tyrosine to competing large neutral amino acids, which is why many trials dose tyrosine after fasting and avoid co-ingestion with high-protein meals (eNeuro). This is also why taking tyrosine inside a protein-heavy pre-workout or meal may not reproduce fasting research effects. > Primary-source quote: “Tyrosine is the precursor of the catecholamines, converted to dopamine via L-Dopa,” the eNeuro older-adult trial notes when explaining its mechanistic rationale (eNeuro).

What works and what doesn't

Claimed benefit	Verdict	Evidence grade	Key evidence	Key caveat
Cognitive performance under acute stress: cold, sleep deprivation, military stress	WORKS for some stress-specific tasks	Moderate	Cold-stress and sleep-loss studies show working-memory or vigilance protection; Military Medicine review says evidence is insufficient for confident recommendations but promising for cognition.	Mostly acute, high-dose, small, often military-relevant studies; not everyday stress.
Working memory in healthy adults	MIXED	Low-to-moderate	2 g L-tyrosine improved demanding 2-back performance in young adults; higher doses worsened high-load working memory in older adults.	Baseline dopamine function, age, dose, task difficulty, and fasting state likely matter.
Physical performance / exercise	MIXED / mostly DOESN'T	Low	Load-carriage heat study found 150 mg/kg did not influence cognitive or exercise outcomes; 2025 soccer heat study found no physical or decision-making benefit.	Some older heat/cycling findings are positive, but replication is weak.
ADHD	INSUFFICIENT EVIDENCE	Very low	Open adult ADD trial showed tolerance by 6 weeks; small single-blind child study found no significant improvement.	Not a substitute for ADHD medication; evidence is old and underpowered.
Depression	DOESN'T for routine major depression	Low-to-moderate	65-person double-blind trial found no antidepressant activity.	Dopamine-dependent depression subgroup claims remain unproven and not generalizable.
Stress resilience / feeling less stressed	MIXED	Low	Evidence supports cognitive preservation under physical/operational stress more than subjective calm.	A severe-stress study found tyrosine increased anger and did not improve most subjective or physiological stress responses.
Phenylketonuria (PKU) supplementation	INSUFFICIENT EVIDENCE for routine extra supplementation beyond specialist diet	Moderate for biochemical increase; low for clinical outcomes	Cochrane: blood tyrosine increased, but no significant differences in other outcomes.	PKU care is medical nutrition therapy; do not self-supplement outside a metabolic clinic.

Original insight: tyrosine is less like “daily motivation” and more like “acute neurotransmitter raw-material insurance” when catecholamine demand is temporarily high. Cited stat: the sleep-deprivation study used 150 mg/kg in a split dose and found performance improvements lasting about three hours (PubMed). Primary-source quote: the 2015 review concluded that “available evidence is insufficient to make confident recommendations,” while adding that tyrosine “may benefit cognitive performance” and deserves further study (Military Medicine).

Benefits by claim

Acute-stress cognition: evidence grade B-

Cold-stress evidence is the cleanest mechanistic story. In one eight-man Naval Medical Research Institute study, 150 mg/kg L-tyrosine given two hours before cold exposure improved delayed matching-to-sample accuracy at the longest delay interval affected by cold, while tyrosine at 22°C had no effect (PubMed). A sleep-loss study found that 150 mg/kg L-tyrosine in a split dose reduced the usual decline on a psychomotor task and reduced lapse probability on a high-event-rate vigilance task for roughly three hours (PubMed).

Working memory and executive control: evidence grade C+

A young-adult N-back study reported that 2 g L-tyrosine improved demanding 2-back but not easier 1-back performance, with no significant changes in heart rate, blood pressure, or mood (Frontiers in Behavioral Neuroscience). The same result should not be generalized to all ages: in a double-blind randomized crossover trial of older adults, 100, 150, and 200 mg/kg produced dose-dependent plasma increases, but higher dose-response was associated with worse high-load working memory (Nutrients).

Physical performance and exercise: evidence grade C-/D

A military-style load-carriage study in 40°C heat concluded that 150 mg/kg L-tyrosine did not influence cognitive function or steady-state exercise or time-trial outcomes after carrying 25 kg (Journal of the International Society of Sports Nutrition). A 2025 soccer-player heat study found no effect of 150 mg/kg L-tyrosine on power output, decision-making, cognitive appraisal, or affective valence during a 92-minute high-intensity intermittent cycling sprint protocol (PLOS One).

ADHD: evidence grade D

The adult ADD signal is weak and short-lived: an open eight-week trial in 12 adults found eight initial responders, but all responders developed tolerance by week six, and the authors concluded L-tyrosine was not useful for residual-type ADD (PubMed). A seven-child single-blind ADDH study found no significant improvement with oral tyrosine (PubMed).

Depression: evidence grade D

A randomized double-blind trial of 65 outpatients with major depression compared L-tyrosine 100 mg/kg/day, imipramine 2.5 mg/kg/day, and placebo for four weeks and found no evidence that tyrosine had antidepressant activity (PubMed). A later mood review stated that the evidence for tyrosine loading as a depression treatment is “even less promising” than tryptophan loading and that the only randomized double-blind tyrosine trial did not show antidepressant benefit (PubMed).

PKU supplementation: evidence grade C

Cochrane's 2021 update included three suitable trials with 56 people, found significantly higher blood tyrosine with supplementation, but found no significant differences in other outcomes and no evidence to routinely add tyrosine in PKU (Cochrane). This does not mean tyrosine is irrelevant in PKU diets; it means extra standalone supplementation should be managed by a metabolic specialist rather than marketed as a cognitive fix.

Risks and ALL side effects

Side effect or concern	Frequency	Dose relationship	What to watch for	Evidence note
GI upset: nausea, stomach discomfort, diarrhea, vomiting	Uncommon / not well quantified	More likely at multi-gram or >150 mg/kg dosing	Nausea, loose stool, vomiting, abdominal discomfort	Commonly reported in clinical summaries; trials often small and short.
Headache	Uncommon / not well quantified	Possible at higher doses or stimulant-like stacks	New or worsening headaches	Reported in safety summaries; frequency not well measured.
Heartburn	Uncommon / not well quantified	May be dose and timing related	Burning, reflux, nausea	Listed by WebMD among side effects some people experience.
Jitteriness, anxiety, irritability, insomnia	Uncommon; risk higher in sensitive users	Higher risk with high doses, late-day use, caffeine, ADHD stimulants, or other catecholamine supplements	Restlessness, anxiety spike, poor sleep, palpitations	Mechanistically plausible; severe-stress study found increased anger.
Blood pressure / pulse changes	Usually not prominent in healthy trials; possible in susceptible people	Higher risk with MAOIs, stimulants, decongestants, hypertension, or high catecholamine load	Headache, chest tightness, high BP, racing pulse	MAOI interaction risk is serious even if direct tyrosine case data are limited.
Potential thyroid disruption	Unclear; not proven for typical low doses	Concern rises with chronic high-dose use, hyperthyroidism, Graves' disease, thyroid medication, or iodine-heavy thyroid stacks	Heat intolerance, tremor, palpitations, anxiety, low TSH/high T3/T4 symptoms	Tyrosine is part of thyroid hormone synthesis; one polar-region study found tyrosine lowered TSH and increased fT3 in winter.
Melanin / pigmentation pathway interactions	Clinical frequency unknown	Not established for oral supplement doses	Do not use as a tanning or pigmentation supplement; use caution with melanoma or pigment disorders until reviewed clinically	Tyrosine and L-DOPA are substrates and regulators of melanogenesis, but oral cosmetic benefit is not established.
Allergic reaction	Rare	Not clearly dose-dependent	Hives, swelling, wheezing, throat tightness	Rare but treat as urgent.

WebMD states that oral tyrosine appears possibly safe short-term at doses up to 150 mg/kg daily for up to three months and lists nausea, headache, fatigue, and heartburn among side effects some people experience (WebMD). The Norwegian Scientific Committee for Food Safety noted that no human tolerable upper intake level has been established and used animal toxicology plus limited human data to assess supplement-dose risk (VKM). > Primary-source quote: in healthy older adults, the dose-response trial concluded that age-related plasma tyrosine increases were “associated with adverse dose-dependent effects of tyrosine administration on cognition” (Nutrients).

ALL interactions

Interacts with	Examples	Severity	Mechanism	Action
MAOIs	Phenelzine, tranylcypromine, isocarboxazid, selegiline, rasagiline, linezolid (MAOI-like antibiotic)	SERIOUS / avoid unless specialist-supervised	MAO inhibition reduces breakdown of monoamines and pressor amines; adding catecholamine precursor or related amines may increase hypertensive-crisis risk.	Avoid self-combination; urgent care for severe headache, chest pain, very high BP, confusion, or neurologic symptoms.
Levodopa / Parkinson's medication	Levodopa-carbidopa, levodopa-benserazide, mucuna pruriens/L-DOPA supplements	Moderate-to-serious	Tyrosine and levodopa are aromatic/large neutral amino-acid pathway competitors at gut and blood-brain transport steps.	Do not start without Parkinson's clinician approval; separate dosing if prescriber permits.
Thyroid medication	Levothyroxine, liothyronine, desiccated thyroid; antithyroid drugs such as carbimazole or propylthiouracil	Moderate / monitor	Tyrosine participates in thyroid hormone synthesis; added precursor may theoretically alter thyroid hormone balance or medication response.	Avoid in hyperthyroidism/Graves'; discuss with clinician and monitor TSH/T3/T4 if used.
Stimulant medicines	Adderall/amphetamine salts, lisdexamfetamine, methylphenidate, modafinil/armodafinil	Moderate; potentially serious in hypertension/anxiety	Additive catecholamine, alerting, blood-pressure, pulse, anxiety, and insomnia burden.	Do not stack casually; monitor BP, pulse, anxiety, and sleep.
Caffeine	Coffee, energy drinks, pre-workouts, caffeine pills	Caution	Caffeine is an adenosine antagonist and can increase alertness, jitteriness, and cardiovascular strain; combined stimulant load may worsen anxiety or insomnia.	Keep caffeine low when testing tyrosine; avoid late-day use.
Other catecholamine-increasing supplements	Yohimbine, synephrine/bitter orange, ephedra/ephedrine, pseudoephedrine, phenylephrine, high-dose green tea extract, rhodiola in sensitive users, mucuna/L-DOPA, phenylalanine	Caution to serious depending on stack	Additive sympathomimetic or dopamine/norepinephrine pathway effects; decongestants and ephedrine-like compounds have blood-pressure risk.	Avoid aggressive “focus” stacks; never combine with MAOIs.
Antidepressants and psychiatric medicines	SNRIs, bupropion, TCAs, antipsychotics, MAOIs, ADHD meds	Caution; MAOIs serious	Potential overlap with dopamine/norepinephrine tone, BP, anxiety, agitation, or sleep.	Use only with prescriber knowledge if you take psychiatric medication.

MAOI interaction concern is mechanistically serious because MAOIs can interact with sympathomimetic agents and pressor amines, and a 2022 review states that hypertensive crisis can arise when MAOIs are combined with L-dopa, methylphenidate, dextroamphetamine, and related agents (Cureus). Levodopa caution is also mechanism-based: a 2023 review explains that levodopa is structurally similar to aromatic amino acids such as phenylalanine, tyrosine, and tryptophan and shares amino-acid transport mechanisms that can reduce bioavailability when competing amino acids are present (NPJ Parkinson's Disease). > Primary-source quote: the MAOI review states that “the most serious, although rare, adverse drug reactions” from combinations with sympathomimetic and serotonergic agents are “serotonin syndrome and hypertensive crisis” (Cureus).

Who should avoid it

Avoid L-tyrosine unless a clinician specifically approves it if you take MAOIs, levodopa/Parkinson's medication, thyroid hormone, antithyroid drugs, prescription stimulants, or high-risk stimulant supplements. Avoid it if you have hyperthyroidism, Graves' disease, uncontrolled hypertension, significant anxiety or panic disorder, bipolar/mania risk, melanoma or active pigment-cell disease under treatment, pregnancy or breastfeeding without clinician approval, or PKU unless managed by a metabolic specialist. A severe psychological-stress study in healthy service members found that tyrosine increased anger but did not change most subjective or physiological stress responses, which is a practical caution for anxiety-prone users (Neuropsychobiology). Tyrosine and L-DOPA also act as substrates and regulators in melanogenesis, so cosmetic tanning claims and melanoma-adjacent use deserve strict caution rather than marketing optimism (Experimental Dermatology).

Dosage and how to take it

Use case	Studied dose range	Practical conservative approach	Timing	Notes
Acute cold / sleep-loss / operational stress	Often 100–150 mg/kg; some studies used up to 20 g or split doses.	Only for short, specific stress events; avoid chronic high-dose use without supervision.	60–120 minutes before demand; some sleep-loss protocols split dosing.	High research doses are not routine daily supplement doses.
General nootropic trial in healthy adult	2 g improved demanding N-back in one young-adult study.	500–2,000 mg in the morning, not daily indefinitely.	Empty stomach or away from protein; avoid late day.	Stop if anxious, jittery, or sleep worsens.
Exercise / pre-workout	Often 150 mg/kg in heat studies.	Not recommended as a core ergogenic aid.	If tested, morning or pre-training only.	Evidence is mixed and often negative.
PKU	100 mg/kg/day in some trials.	Only under metabolic clinic supervision.	Per medical nutrition plan.	Cochrane does not support routine extra supplementation for clinical outcomes.
NALT	5 g IV in human precursor study.	Prefer free-form L-tyrosine if the goal is raising tyrosine.	Not applicable.	NALT is not better supported for bioavailability.

For acute cognitive-stress experiments, many studies used 150 mg/kg, which equals 10.5 g for a 70 kg adult; this is research-style dosing, not a casual daily dose. Plasma tyrosine rises dose-dependently and can remain elevated for hours, but older adults had stronger plasma responses and worse high-load working memory at higher doses in the dose-response trial (Nutrients).

Infographics and text equivalents

Infographic 1: Tyrosine pathway map

L-tyrosine: the biochemical crossroads
L-tyrosine
Catecholamines	L-DOPA → dopamine → norepinephrine → epinephrine
Thyroid hormones	Tyrosine residues+ iodine → T3/T4
Melanin	Tyrosinase pathway → L-DOPA / dopaquinone

Text version of this infographic

L-tyrosine is a precursor for three major pathways: catecholamines, thyroid hormones, and melanin. In the catecholamine pathway, L-tyrosine is converted to L-DOPA, then dopamine, then norepinephrine, then epinephrine. In thyroid hormone synthesis, tyrosine residues in thyroglobulin are iodinated and coupled to form T3 and T4. In melanogenesis, tyrosine enters the tyrosinase pathway to form L-DOPA, dopaquinone, and melanin pigment.

Infographic 2: Acute-stress cognitive benefit window

Infographic 3: Evidence strength by claim

Evidence strength: claim-by-claim
Acute stress cognition	Moderate
Working memory	Mixed
Exercise performance	Weak
ADHDInsufficient	Depression
Negative	PKU routine add-on
Biochemical only

Claim	Evidence strength
Acute stress cognition	Moderate
Working memory	Mixed
Exercise performance	Weak
ADHD	Insufficient
Depression	Negative
PKU routine add-on	Biochemical increase only; insufficient clinical outcome evidence

Infographic 4: Dosing decision guide

Dose with the situation, not the hype	Low trial
500–2,000 mg	Morning only
Away from protein	Stop if anxious
Research dose	100–150 mg/kg
Acute stress only	60–120 min before
Not daily routine	Avoid / ask doctor
MAOI / levodopa	Thyroid meds
Stimulants	Hyperthyroid / anxiety

Text version of this infographic

Low trial: 500–2,000 mg in the morning, away from protein, and stop if anxiety or insomnia appears. Research dose: 100–150 mg/kg, used for acute stress only, usually 60–120 minutes before the stressor, and not as routine daily use. Avoid or ask a doctor first if using MAOIs, levodopa, thyroid medication, prescription stimulants, or if you have hyperthyroidism or significant anxiety.

Infographic 5: Interaction matrix

Interaction matrix	MAOIs
SERIOUS: hypertensive-crisis risk; avoid self-combination	Levodopa
Transport competition; may reduce Parkinson's medication effect	Thyroid meds
Precursor overlap; monitor TSH/T3/T4	Stimulants + caffeine
Additive jitteriness, anxiety, pulse, sleep disruption	Other catecholamine stacks
Yohimbine, synephrine, decongestants, mucuna: use caution

Interaction	Severity	Reason
MAOIs	Serious	Hypertensive-crisis risk; avoid self-combination.
Levodopa	Moderate to serious	Transport competition may reduce Parkinson's medication effect.
Thyroid medication	Moderate	Precursor overlap; monitor TSH/T3/T4.
Stimulants and caffeine	Caution to moderate	Additive jitteriness, anxiety, pulse, and sleep disruption.
Other catecholamine stacks	Caution	Yohimbine, synephrine, decongestants, and mucuna may add sympathetic or dopamine-pathway effects.

Infographic 6: NALT vs L-tyrosine

NALT vs free-form L-tyrosine	Free-form L-tyrosine
Used in most human trials	Raises plasma tyrosine
Best choice for evidence-based use	NALTMore water-soluble
Poor human conversion signal	56% excreted after 5 g IV

Feature	Free-form L-tyrosine	NALT
Solubility	Lower	Higher
Human evidence	Used in most cognition/stress trials	Human IV precursor data show poor conversion
Plasma tyrosine effect	Dose-dependent increase	5 g IV raised plasma tyrosine only 25% in one study
Waste/excretion signal	Not the main concern	56% excreted unchanged in urine after 5 g IV in one human study
Verdict	Preferred	Not superior despite better solubility

Related research

For deeper, evidence-graded context on the conditions L-tyrosine is most often used for, see Pure City Research's condition guides: - Stress, anxiety & depression: prevention and management guide

Frequently Asked Questions

Does L-tyrosine increase dopamine?

L-tyrosine is the biochemical precursor to L-DOPA and dopamine, but taking more tyrosine does not guarantee a simple or linear dopamine boost in daily life. Evidence is strongest when catecholamine demand is high, such as cold stress or sleep deprivation, rather than when a rested person wants extra motivation (NCBI Bookshelf, Journal of Psychiatry & Neuroscience).

Is L-tyrosine good for studying or exams?

It may help demanding working-memory tasks under acute stress, but the evidence does not support using it as a universal study pill. A 2 g study improved 2-back performance in young adults, while older-adult high-dose work found possible cognitive worsening at higher doses (Frontiers in Behavioral Neuroscience, Nutrients).

Is NALT better than L-tyrosine?

No strong human evidence shows NALT is better. NALT is more water-soluble, but a human IV study found 56% urinary excretion and only a 25% plasma tyrosine increase after 5 g, making free-form L-tyrosine the more evidence-based supplement form (PubMed).

Can I take L-tyrosine with Adderall or caffeine?

Do not stack L-tyrosine with Adderall, other stimulants, or high caffeine without medical guidance if you have anxiety, insomnia, hypertension, palpitations, or psychiatric medication use. The concern is additive catecholamine and stimulant burden, especially because tyrosine is upstream of dopamine and norepinephrine (NCBI Bookshelf, Cureus).

Can L-tyrosine help ADHD?

Current evidence is insufficient. One open adult ADD study found early response but tolerance by week six, and a small single-blind child ADDH study found no significant improvement (PubMed, PubMed).

Can L-tyrosine help depression?

Routine use for depression is not supported. A 65-person double-blind trial found no evidence of antidepressant activity for 100 mg/kg/day L-tyrosine over four weeks (PubMed).

Is L-tyrosine safe with thyroid medication?

Use caution and involve the clinician managing your thyroid medication. Tyrosine participates in thyroid hormone synthesis, WebMD warns that taking tyrosine with thyroid hormone pills might cause too much thyroid hormone effect, and a seasonal Antarctic study found tyrosine lowered TSH and modestly increased fT3 in winter (WebMD, PubMed).

Is L-tyrosine permitted as a supplement

Yes. L-tyrosine is a naturally occurring amino acid sold legally as a dietary supplement in the United States (as a dietary ingredient under DSHEA), the European Union, the United Kingdom, Canada and most other markets. It is not a controlled substance and does not require a prescription. Like other amino-acid supplements it is regulated for safety and accurate labelling rather than pre-approved for specific health claims, and people with phenylketonuria (PKU) or those taking MAOI antidepressants or levodopa should check with a clinician before use.

Sources

1. Young SN. L-Tyrosine to alleviate the effects of stress? Journal of Psychiatry & Neuroscience. 2007. PMC
2. Attipoe S, Zeno SA, Lee C, et al. Tyrosine for Mitigating Stress and Enhancing Performance in Healthy Adult Humans, a Rapid Evidence Assessment of the Literature. Military Medicine. 2015. Oxford Academic
3. Shurtleff D, Thomas JR, Schrot J, Kowalski K, Harford R. Tyrosine reverses a cold-induced working memory deficit in humans. Pharmacology Biochemistry and Behavior. 1994. PubMed
4. Neri DF, Wiegmann D, Stanny RR, Shappell SA, McCardie A, McKay DL. The effects of tyrosine on cognitive performance during extended wakefulness. Aviation, Space, and Environmental Medicine. 1995. PubMed
5. Deijen JB, Wientjes CJ, Vullinghs HF, Cloin PA, Langefeld JJ. Tyrosine improves cognitive performance and reduces blood pressure in cadets after one week of a combat training course. Brain Research Bulletin. 1999. PubMed
6. Lieberman HR. Tyrosine and its potential use as a countermeasure to performance decrement in military sustained operations. Aviation, Space, and Environmental Medicine. 1992. PubMed
7. Lieberman HR. Nutrition, brain function and cognitive performance. Appetite. 2003. PubMed
8. ClinicalTrials.gov. Effect of Tyrosine Supplementation on Cognitive Performance and Mood During Military Stress. ClinicalTrials.gov
9. Colzato LS, Jongkees BJ, Sellaro R, Hommel B. Working Memory Reloaded: Tyrosine Repletes Updating in the N-Back Task. Frontiers in Behavioral Neuroscience. 2013. PMC
10. van de Rest O, Bloemendaal M, de Heus R, Aarts E. Dose-Dependent Effects of Oral Tyrosine Administration on Plasma Tyrosine Levels and Cognition in Aging. Nutrients. 2017. PMC
11. Bloemendaal M, Zandbelt BB, Wegman J, et al. Neuro-Cognitive Effects of Acute Tyrosine Administration on Reactive and Proactive Response Inhibition in Healthy Older Adults. eNeuro. 2018. PMC
12. Chrismas B, Taylor L, et al. Effect of tyrosine ingestion on cognitive function and load carriage performance in the heat. Journal of the International Society of Sports Nutrition. 2015. PMC
13. Donnan KJ, Williams EL, Stanger N. Tyrosine supplementation is ineffective in facilitating soccer players' physical and cognitive performance during high-intensity intermittent exercise in hot conditions. PLOS One. 2025. PMC
14. Juaneza A, Davidson C, Santos EN, et al. Effects of acute caffeine, theanine and tyrosine supplementation on mental and physical performance in athletes. Journal of the International Society of Sports Nutrition. 2019. PMC
15. Reimherr FW, Wender PH, Wood DR, Ward M. An open trial of L-tyrosine in the treatment of attention deficit disorder, residual type. American Journal of Psychiatry. 1987. PubMed
16. Nemzer E, Arnold LE, Votolato NA, McConnell H. Effect of tyrosine on attention deficit disorder with hyperactivity. Journal of Clinical Psychiatry. 1988. PubMed
17. Gelenberg AJ, Gibson CJ, Wojcik JD. Tyrosine for depression: a double-blind trial. Journal of Affective Disorders. 1990. PubMed
18. Parker G, Brotchie H. Mood effects of the amino acids tryptophan and tyrosine. Acta Psychiatrica Scandinavica. 2011. PubMed
19. Remmington T, Smith S. Tyrosine supplementation for phenylketonuria. Cochrane Database of Systematic Reviews. 2021. Cochrane
20. Smith ML, Hanley WB, Clarke JTR, et al. Randomised controlled trial of tyrosine supplementation on neuropsychological performance in phenylketonuria. Archives of Disease in Childhood. 1998. PMC
21. Magnusson I, et al. N-acetyl-L-tyrosine and N-acetyl-L-cysteine as tyrosine and cysteine precursors during intravenous infusion in humans. PubMed
22. Saavedra JM, et al. Brain tyrosine increases after treating with prodrugs. PubMed
23. Khalil B, et al. Physiology, Catecholamines. StatPearls / NCBI Bookshelf. NCBI Bookshelf
24. Schlessinger D, Rahimi N, Schlessinger J. Biochemistry, Melanin. StatPearls / NCBI Bookshelf. NCBI Bookshelf
25. PubChem PathBank. Tyrosine Metabolism Pathway. PubChem
26. Slominski A, et al. L-tyrosine and L-DOPA as hormone-like regulators of melanocytes. Experimental Dermatology. 2011. PMC
27. Gillman PK, et al. Clinically Relevant Drug Interactions with Monoamine Oxidase Inhibitors. Cureus. 2022. PMC
28. Virmani T, et al. To restrict or not to restrict? Practical considerations for optimizing dietary protein interactions on levodopa absorption in Parkinson's disease. NPJ Parkinson's Disease. 2023. PMC
29. WebMD. Tyrosine: Uses, Side Effects, and More. WebMD
30. Norwegian Scientific Committee for Food Safety. Risk assessment of “other substances” – L-tyrosine. VKM
31. Food Safety and Standards Authority of India. Direction under Section 16(5) of FSS Act regarding Health Supplements/Nutraceuticals.